This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
Why upscheduling codeine combination products is a really bad idea
Previous Situation stable: 2015 UTS Pharmacy Barometer
Next Generic Medicines Working Group identifies priorities
Related Posts
Codeine quantities confirmed
No lasting increase in low-dose codeine use following upscheduling, TGA says, as study reveals pharmacists' post-schedule experiences The Therapeutic Goods Administration (TGA) has found there was a temporary spike in the use of high-strength codeine after its 2018 upscheduling, but this subsequently diminished entirely over time. The agency recently completed and…
Why upscheduling codeine won’t solve any problem
The rescheduling of OTC codeine-containing analgesics to prescription only won’t reduce misuse or increase patient safety, writes Professor Peter Carroll I believe the TGA’s decision to upschedule OTC codeine-containing preparations will do nothing to identify or help those people who may be dependent on codeine. It will merely force these…
Upscheduling codeine disregards pharmacist expertise: ASMI
The Australian Self Medication Industry has restated its support for retaining the current status of over-the-counter codeine-containing analgesics. The statement follows several mainstream media reports over the last 24 hours, such as this Adelaide Advertiser story, suggesting that currently scheduled Pharmacist Only codeine-containing preparations may soon go prescription only. ASMI…